Limiting immune activation by “self” RNAs
Nature Immunology
July 28, 2014
The enzyme SKIV2L detects and destroys aberrant forms of cellular RNA before they can trigger potentially harmful immune responses according to a report published this week in Nature Immunology. These findings may have implications for autoimmune syndromes, such as lupus, associated with excessive type I interferon immune cell production.
Dan Stetson and colleagues show that the loss of the enzyme SKIV2L enhances RNA-mediated activation of cellular sensors that normally guard against RNA virus infection. SKIV2L-deficient cells are also more sensitive to a type of cellular stress called the unfolded protein response, which is often observed in highly secretory cells, such as those found in salivary glands. They find this stress produces aberrant “self” RNAs that likewise trigger the cellular RNA sensors, leading to the production of potent immune activators called type I interferons. This response, if unchecked, can lead to immunopathology. Pediatric patients with inherited deficiencies of SKIV2L likewise exhibit a strong “type I interferon signature”.
The authors speculate that certain autoimmune diseases, such as Sjogren’s syndrome and type I diabetes, may be linked to SKIV2L.
doi: 10.1038/ni.2948
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature